Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of DTaP or DT in 6 Years Old Children
NCT05870618Phase 4Unknown
- Start
- May 2023
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of diphtheria + tetanus + acellular pertussis vaccine and diphtheria and tetanus toxoids in diphtheria, Tetanus and pertussis (2 arms). Primary endpoints: Seroconversion rates of the vaccination and Seropositive rates after the vaccination. Status: unknown.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccinediphtheria and tetanus toxoids
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT05870618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05870618.